Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Sales | 8,050,000 | 8,357,000 | 7,821,000 | 6,283,000 | 5,624,000 |
| Cost of Goods | 2,469,000 | 2,342,000 | 2,207,000 | 1,386,000 | 1,292,000 |
| Gross Profit | 5,581,000 | 6,015,000 | 5,614,000 | 4,897,000 | 4,332,000 |
| Operating Expenses | 7,086,000 | 6,029,000 | 8,563,000 | 3,929,000 | 2,758,000 |
| Operating Income | -1,505,000 | -14,000 | -2,949,000 | 968,000 | 1,574,000 |
| Interest Expense | 468,000 | 570,000 | 435,000 | 90,000 | 64,000 |
| Other Income | -58,000 | 15,000 | -151,000 | 13,000 | -16,000 |
| Pre-tax Income | -2,031,000 | -569,000 | -3,535,000 | 891,000 | 1,494,000 |
| Income Tax | 5,000 | -74,000 | 42,000 | 263,000 | 432,000 |
| Net Income Continuous | -2,036,000 | -495,000 | -3,577,000 | 628,000 | 1,062,000 |
| Net Income | $-2,036,000 | $-495,000 | $-3,577,000 | $628,000 | $1,062,000 |
| EPS Basic Total Ops | -1.36 | -0.33 | -2.81 | 0.76 | 1.27 |
| EPS Basic Continuous Ops | -1.36 | -0.33 | -2.81 | 0.76 | 1.27 |
| EPS Diluted Total Ops | -1.36 | -0.33 | -2.81 | 0.75 | 1.24 |
| EPS Diluted Continuous Ops | -1.36 | -0.33 | -2.81 | 0.75 | 1.24 |
| EBITDA(a) | $2,149,000 | $925,000 | $-2,168,000 | $1,282,000 | $1,849,000 |